Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1988 Oct;85(19):7197–7201. doi: 10.1073/pnas.85.19.7197

Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C.

P A Wender 1, C M Cribbs 1, K F Koehler 1, N A Sharkey 1, C L Herald 1, Y Kamano 1, G R Pettit 1, P M Blumberg 1
PMCID: PMC282151  PMID: 3174627

Abstract

The bryostatins are macrocyclic lactones that represent an additional structural class of potent activators of protein kinase C. These marine animal biosynthetic products are of unusual interest because they induce only a subset of the biological responses induced by the phorbol esters. We have now determined the binding affinities of naturally occurring and semisynthetic bryostatins for protein kinase C by competition analysis with [26-3H]bryostatin 4 as the radioactive ligand. Esterification of the hydroxyl group at C26 caused dramatic loss of activity as did inversion of the asymmetric center at this position. In contrast, neither of the ester groups at C7 and C20 had a major influence on activity. Computer modeling of the phorbol esters, related diterpenes, and indole alkaloids suggested that the C20, C9, and C4 oxygens of phorbol represented critical elements of the phorbol ester pharmacophore. The C26 oxygen of the bryostatins, together with the C1 and C19 oxygens, gave an excellent spatial correlation with this model, with a root-mean-square deviation of 0.16 A (compared to 0.10-0.35 A among phorbol-related diterpenes). The extension of the phorbol ester pharmacophore model to the bryostatins and its agreement with the structure-activity relations for the bryostatin class of compounds provide additional support for the validity of the model.

Full text

PDF
7197

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashendel C. L. The phorbol ester receptor: a phospholipid-regulated protein kinase. Biochim Biophys Acta. 1985 Sep 9;822(2):219–242. doi: 10.1016/0304-4157(85)90009-7. [DOI] [PubMed] [Google Scholar]
  2. Berkow R. L., Kraft A. S. Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol ester receptor. Biochem Biophys Res Commun. 1985 Sep 30;131(3):1109–1116. doi: 10.1016/0006-291x(85)90205-0. [DOI] [PubMed] [Google Scholar]
  3. Blumberg P. M. Protein kinase C as the receptor for the phorbol ester tumor promoters: sixth Rhoads memorial award lecture. Cancer Res. 1988 Jan 1;48(1):1–8. [PubMed] [Google Scholar]
  4. Cheng Y., Prusoff W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
  5. Delclos K. B., Yeh E., Blumberg P. M. Specific labeling of mouse brain membrane phospholipids with [20-3H]phorbol 12-p-azidobenzoate 13-benzoate, a photolabile phorbol ester. Proc Natl Acad Sci U S A. 1983 May;80(10):3054–3058. doi: 10.1073/pnas.80.10.3054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dell'Aquila M. L., Herald C. L., Kamano Y., Pettit G. R., Blumberg P. M. Differential effects of bryostatins and phorbol esters on arachidonic acid metabolite release and epidermal growth factor binding in C3H 10T1/2 cells. Cancer Res. 1988 Jul 1;48(13):3702–3708. [PubMed] [Google Scholar]
  7. Dell'Aquila M. L., Nguyen H. T., Herald C. L., Pettit G. R., Blumberg P. M. Inhibition by bryostatin 1 of the phorbol ester-induced blockage of differentiation in hexamethylene bisacetamide-treated Friend erythroleukemia cells. Cancer Res. 1987 Nov 15;47(22):6006–6009. [PubMed] [Google Scholar]
  8. Hennings H., Blumberg P. M., Pettit G. R., Herald C. L., Shores R., Yuspa S. H. Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin. Carcinogenesis. 1987 Sep;8(9):1343–1346. doi: 10.1093/carcin/8.9.1343. [DOI] [PubMed] [Google Scholar]
  9. Jeng A. Y., Sharkey N. A., Blumberg P. M. Purification of stable protein kinase C from mouse brain cytosol by specific ligand elution using fast protein liquid chromatography. Cancer Res. 1986 Apr;46(4 Pt 2):1966–1971. [PubMed] [Google Scholar]
  10. Kraft A. S., Smith J. B., Berkow R. L. Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60. Proc Natl Acad Sci U S A. 1986 Mar;83(5):1334–1338. doi: 10.1073/pnas.83.5.1334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nishizuka Y. Studies and perspectives of protein kinase C. Science. 1986 Jul 18;233(4761):305–312. doi: 10.1126/science.3014651. [DOI] [PubMed] [Google Scholar]
  12. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature. 1984 Apr 19;308(5961):693–698. doi: 10.1038/308693a0. [DOI] [PubMed] [Google Scholar]
  13. Pettit G. R., Kamano Y., Herald C. L. Antineoplastic agents, 118. Isolation and structure of bryostatin 9. J Nat Prod. 1986 Jul-Aug;49(4):661–664. doi: 10.1021/np50046a017. [DOI] [PubMed] [Google Scholar]
  14. Sako T., Yuspa S. H., Herald C. L., Pettit G. R., Blumberg P. M. Partial parallelism and partial blockade by bryostatin 1 of effects of phorbol ester tumor promoters on primary mouse epidermal cells. Cancer Res. 1987 Oct 15;47(20):5445–5450. [PubMed] [Google Scholar]
  15. Smith J. B., Smith L., Pettit G. R. Bryostatins: potent, new mitogens that mimic phorbol ester tumor promoters. Biochem Biophys Res Commun. 1985 Nov 15;132(3):939–945. doi: 10.1016/0006-291x(85)91898-4. [DOI] [PubMed] [Google Scholar]
  16. Suganuma M., Fujiki H., Tahira T., Cheuk C., Moore R. E., Sugimura T. Estimation of tumor promoting activity and structure-function relationships of aplysiatoxins. Carcinogenesis. 1984 Mar;5(3):315–318. doi: 10.1093/carcin/5.3.315. [DOI] [PubMed] [Google Scholar]
  17. Wender P. A., Koehler K. F., Sharkey N. A., Dell'Aquila M. L., Blumberg P. M. Analysis of the phorbol ester pharmacophore on protein kinase C as a guide to the rational design of new classes of analogs. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4214–4218. doi: 10.1073/pnas.83.12.4214. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES